The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas
Zhiguo Zhang(Cancer Research Center), Jeong‐Heon Lee(Mayo Clinic), André J. van Wijnen(University of Vermont), Elizabeth W. Bradley(University of Minnesota), Hui Zhou(Sun Yat-sen University), Julia A. Bridge(Nebraska Medical Center), Jennifer J. Westendorf(Mayo Clinic in Arizona), Tamás Ördög(Mayo Clinic), Scott M. Riester(Mayo Clinic), Long Jin(Nanjing Agricultural University), Rui-Ming Xu(Qinghai University), Thai H. Ho(Mayo Clinic in Arizona), Jinglong Wang(Stanford University), Jianji Chen(University of Minnesota), André M. Oliveira(Mayo Clinic in Arizona), Haiyun Gan(State Key Laboratory of Synthetic Chemistry), Stephen N. Thibodeau(Mayo Clinic in Arizona), Yue Chen(Capital Medical University), Na Yang(University of Electronic Science and Technology of China), Zhiquan Wang(Mayo Clinic in Arizona), Honglian Zhang, Brian P. Rubin(Cleveland Clinic), Jing Han(Mayo Clinic)
Cited by 283
Related Papers
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27
|Genes & Development|2003|653